The Latest Breaking News from Disease

Lakshmi (name changed), a school headmistress, was well-known for her warmth, boundless energy and legendary parties. A few years after retirement, she began to wane with mild signs of cognitive decline, which quickly deteriorated into dementia after the loss of her husband.

Under current laws, rescue organisations are not required to be licensed in England, Wales or Northern Ireland.

The RSPCA likened the process to ‘Deliveroo for dogs’

From acute viral infection to ‘zombie’ vessels

Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms. These include chronic fatigue, brain fog, exercise intolerance, dizziness, muscle or joint pain and gut problems. And many of these symptoms worsen after exercise, a phenomenon known as post-exertional malaise.

Fast food is everywhere. It’s quick, cheap, and sometimes feels like the only option when you’re busy. But some fast-food items are so loaded with unhealthy ingredients that nutritionists quietly warn they might be even worse for your health than cigarettes. That’s a bold claim, but it’s not just about…

Nicola Fairley is one of 38 cases of botulism so far linked to unlicensed anti-wrinkle injections in recent outbreak of disease many doctors have never treated.

Lunch meats might seem like a quick and easy option for sandwiches, wraps, or snack boards—but not all deli slices are created equal. While some brands now offer “natural” or “nitrate-free” labels, many of these meats are still loaded with sodium, preservatives, and questionable ingredients. According to registered dietitians and…

The heavy metal legend was diagnosed with genetic Parkinson’s disease more than 20 years ago

UK-first scheme also aims to improve access to wider range of food for people with coeliac disease and gluten intolerance

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Friday recommending Eli Lilly and Co.’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease in adults with confirmed amyloid pathology who are apolipoprotein E ε4 (ApoE4) heterozygotes or non-carriers.